Question 1

What is the analyst consensus rating for HAE?

Accepted Answer

The analyst consensus rating for HAE is "Buy" based on 8 analyst recommendations.

Question 2

What is the average price target for HAE?

Accepted Answer

The average 12-month price target for HAE is $76.71, representing an upside of 5.3% from the current price of $72.87.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jun 15, 2026	Anthony Petrone	Mizuho	Maintains	Buy	$70.00 → $85.00 +15.00 (21.4%)
Jun 5, 2026	Travis Steed	BofA Securities	Maintains	Buy	$80.00
May 28, 2026	Joanne Wuensch	Citi	Maintains	Hold	$64.00 → $70.00 +6.00 (9.4%)
May 12, 2026	Michael Petusky	Barrington	Maintains	Buy	$94.00 → $89.00 -5.00 (-5.3%)
May 8, 2026	Rohin K Patel	JP Morgan	Reiterates	Hold	$74.00 → $62.00 -12.00 (-16.2%)
May 8, 2026	David Rescott	Baird	Maintains	Buy	$72.00 → $67.00 -5.00 (-6.9%)
May 7, 2026	Michael Matson	Needham	Maintains	Hold	-
Apr 13, 2026	Anthony Petrone	Mizuho	Maintains	Buy	$80.00 → $70.00 -10.00 (-12.5%)
Apr 13, 2026	Marie Thibault	BTIG	Maintains	Buy	$88.00 → $84.00 -4.00 (-4.5%)

Haemonetics Corporation (HAE) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest HAE Analyst Ratings & Recommendations

Frequently Asked Questions